The South African Health Products Regulatory Authority said these conditions include among others strengthened screening and monitoring of participants at high risk of a blood clotting disorder.

South Africa paused J&J vaccines after health agencies last week called for their suspension in the US. The J&J shot is a key element to South Africa’s vaccination plan and has already been used to inoculate health workers, with no reported adverse effects.

Aspen Pharmacare will manufacture the J&J vaccine in South Africa.

Moneyweb